Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome

NCT05421208 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT05421208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05421208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome
Lead sponsor
Vanderbilt University Medical Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 1, 2022
Completion date
June 30, 2027
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long covid, post-acute covid-19 syndrome, postural tachycardia syndrome (pots), sars cov 2 infection